Latest Publications

Development of resistance to type II JAK2 inhibitors in MPN depends on AXL kinase and is targetable. Codilupi T, Szibinki J, Arunasalam S, Jungius  S, Dunbar AC, Stivala S, Brkic S, Albrecht C, Vokalova L, Yang JL, Buczak K, Ghosh N, Passweg JR, Rovo A, Angelillo-Scherrer A, Pankov D, Dirnhofer S, Levine RL, Koche R, Meyer SC. Clin Cancer Res. 2024 Feb 1;30(3):586-599.  doi: 10.1158/1078-0432.CCR-23-0163. https://aacrjournals.org/clincancerres/article/30/3/586/733543/Development-of-Resistance-to-Type-II-JAK2
Sequential maturation of stimulus-specific adaptation in the mouse lemniscal auditory system. Valerio P, Rechenmann J, Joshi S, De Franceschi G, Barkat Rinaldi T. Sci Adv. 2024 Jan 5;10(1):eadi7624.  doi: 10.1126/sciadv.adi7624.  Epub 2024 Jan 3. https://pubmed.ncbi.nlm.nih.gov/38170771/
Effects of calibrated blue–yellow changes in light on the human circadian clock. Blume Ch, Cajochen Ch, Schöllhorn I, Slawik H C, Spitschan M. Nat Hum Behav. 2023 Dec 22.  doi: 10.1038/s41562-023-01791-7.  Online ahead of print. https://www.nature.com/articles/s41562-023-01791-7#author-information
The Flt3-inhibitor quizartinib augments apoptosis and promotes maladaptive remodeling after myocardial infarction in mice. Belik DM, Bernasconi R, Xu L, Verde GD, Lorenz V, Grüterich V, Balzarolo M, Mochizuki M, Pfister O, Kuster GM. Apoptosis (2023). doi.org/10.1007/s10495-023-01911-8 https://link.springer.com/article/10.1007/s10495-023-01911-8

Research Groups